Comparing Epclusa vs Vosevi
| Epclusa (sofosbuvir / velpatasvir) | Vosevi (sofosbuvir / velpatasvir / voxilaprevir) |
|
|---|
| Epclusa (sofosbuvir / velpatasvir) | Vosevi (sofosbuvir / velpatasvir / voxilaprevir) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Epclusa is a combination tablet containing velpatasvir and sofosbuvir. It may be used to treat all six genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Prescription only
Vosevi is a stand-alone combination antiviral treatment that may be used to treat HCV infection of genotypes 1 through 6 in adults who have been previously treated with certain other antiviral... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
| More about Epclusa (sofosbuvir / velpatasvir) | More about Vosevi (sofosbuvir / velpatasvir / voxilaprevir) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Epclusa has an average rating of 7.6 out of 10 from a total of 407 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 12% reported a negative effect. |
Vosevi has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Epclusa side effects |
View all Vosevi side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Epclusa prices |
View all Vosevi prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
27 hours |
33 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 201 drugs are known to interact with Epclusa:
|
A total of 237 drugs are known to interact with Vosevi:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
June 28, 2016 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.